Tag: Charlie Kim
Shashwat Tewary moves to Cooley as partner in Singapore
Shashwat Tewary has joined Cooley’s Singapore office as a capital markets partner, bringing 16 years of regional experience
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each
LATEST ON LAW.ASIA
The AI data squeeze
PatSnap compliance chief on AI data compliance under dual US-China rules
MOST READ ON LAW.ASIA
HKEX opens up
SEHK’s 24 July 2026 conclusions launch flexible Hong Kong listing reforms amid global IPO rivalry
Innovation shifts gears
The innovation engine is shifting gear. Whoever recalibrates the timing will lead through the next bend.
